Document Detail


Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis.
MedLine Citation:
PMID:  21406175     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In multiple sclerosis, long-term disability is caused by axonal and neuronal damage. Established therapies target primarily the inflammatory component of the disease, but fail to prevent neurodegeneration. Fingolimod (codenamed FTY720) is an oral sphingosine 1-phosphate (S1P) receptor modulator with promising results in phase II trials in multiple sclerosis patients and is under further development as a novel treatment for multiple sclerosis. To evaluate whether FTY720 has neuroprotective properties, we tested this drug in a rat model of myelin oligodendrocyte glycoprotein-induced optic neuritis. FTY720 exerted significant anti-inflammatory effects during optic neuritis and reduced inflammation, demyelination, and axonal damage; however, FTY720 treatment did not prevent apoptosis of retinal ganglion cells (RGCs), the neurons that form the axons of the optic nerve. Consistent with this lack of effect on RGC survival, FTY720 treatment did not improve visual function, nor did it prevent apoptosis of RGCs in vitro. We observed a persistent activation of apoptotic signaling pathways in RGCs under FTY720 treatment, a possible underlying mechanism for the lack of neuroprotection in the presence of strong anti-inflammatory effects, Furthermore, FTY720 shifted the remaining inflammation in the optic nerve toward neurotoxicity by modest up-regulation of potential neurotoxic cytokines. We conclude that FTY720-induced anti-inflammation and axon protection did not of itself protect neurons from apoptotic cell death.
Authors:
Christian R Rau; Katharina Hein; Muriel B Sättler; Benedikt Kretzschmar; Carina Hillgruber; Bradford L McRae; Ricarda Diem; Mathias Bähr
Related Documents :
16937495 - Caffeic acid phenethyl ester modifies the th1/th2 balance in ileal mucosa after gamma-i...
17632405 - Regulation of t-cell immunity by t-cell immunoglobulin and mucin domain proteins.
8951535 - The 1996 moyer award. effects of endotoxin on the th1/th2 response in humans.
10958385 - Th1 and th2 cytokine profile in patients with early onset periodontitis and their healt...
15276025 - Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune ...
12195785 - Increased t-lymphocyte apoptosis/necrosis and il-10 producing cells in patients and the...
Publication Detail:
Type:  Journal Article     Date:  2011-02-26
Journal Detail:
Title:  The American journal of pathology     Volume:  178     ISSN:  1525-2191     ISO Abbreviation:  Am. J. Pathol.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-25     Completed Date:  2011-07-15     Revised Date:  2012-04-02    
Medline Journal Info:
Nlm Unique ID:  0370502     Medline TA:  Am J Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1770-81     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Neurology, University Medicine Göttingen, Göttingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Inflammatory Agents / pharmacology*
Apoptosis
Cytokines / metabolism
Disease Models, Animal
Electrophysiology / methods
Encephalomyelitis, Autoimmune, Experimental / immunology
Female
Glycoproteins / metabolism
Immunosuppressive Agents / pharmacology
Myelin Sheath / metabolism
Neurons / cytology*
Oligodendroglia / metabolism
Optic Neuritis / metabolism*
Propylene Glycols / pharmacology*
Rats
Sphingosine / analogs & derivatives*,  pharmacology
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Cytokines; 0/Glycoproteins; 0/Immunosuppressive Agents; 0/Propylene Glycols; 123-78-4/Sphingosine; 162359-55-9/fingolimod

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis.
Next Document:  Hepatic lipase, high density lipoproteins, and hypertriglyceridemia.